VastBiome is a DNA-first drug discovery company mapping the human gut microbiome in pursuit of novel medicines for cancer and autoimmune disease. VastBiome’s discovery platform leverages rich metagenome sequencing, cell-free expression, and artificial intelligence (AI) to identify potent natural compounds and to scale and extend those products through synthetic biology.
